Targeting viral entry as a strategy for broad-spectrum antivirals [version 1; peer review: 3 approved]

Cited by papers we hold 3

• Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing · 2020
  No notice
• The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target · 2020
  No notice
• Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.